PenderFund Capital Management »

Intercept Pharmaceuticals In Note 2.000 5/1 bnd shares owned by PenderFund Capital Management

Quarter-by-quarter ownership of Intercept Pharmaceuticals In Note 2.000 5/1 bnd shares owned by PenderFund Capital Management from 13F filings

Historical chart of PenderFund Capital Management investment in Intercept Pharmaceuticals In Note 2.000 5/1 bnd

Tip: Access up to 7 years of quarterly data

All positions including Intercept Pharmaceuticals In Note 2.000 5/1 bnd held by PenderFund Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intercept Pharmaceuticals In Note 2.000 5/1 bnd by PenderFund Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $13M 9.3M 1.35
2023-06-30 $13M 12M 1.07
2023-03-31 $13M 12M 1.13
2022-12-31 $12M 12M 1.02
2022-09-30 $12M 12M 1.05
2022-06-30 $10M 12M 0.85
2021-06-30 $5.4M 6.5M 0.83
2021-03-31 $5.4M 6.5M 0.83
2020-12-31 $3.8M 5.0M 0.77
2020-09-30 $4.7M 5.0M 0.94

More positions owned by PenderFund Capital Management

Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
First Majestic Silver Corp Note 0.375% 1/1 (Principal)
Ssr Mining In Note 2.500% 4/0 (Principal)
Opko Health Note 4.500% 2/1 (Principal)
Bandwidth Note 0.500% 4/0 (Principal)
PAR Technology Corporation (PAR)
Burford Cap Ord Shs (BUR)
Sangoma Technologies Corp Com New (SANG)
Nuveen Insured Tax-Free Adv Munici (NEA)
Nuveen Div. Advantage Muni. Fund (NAD)
Nuveen Municipal Credit Com Sh Ben Int (NZF)
Nuveen Insd Dividend Advantage (NVG)
Docebo (DCBO)
Kkr & Co (KKR)
Morgan Stanley Emerging Markets Domestic (EDD)

View all positions for PenderFund Capital Management

Top funds holding Intercept Pharmaceuticals In Note 2.000 5/1 bnd

Ubs Global Asset Management Americas

View all funds holding Intercept Pharmaceuticals In Note 2.000 5/1 bnd